Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Indiana’s Healthcare Sector Gains as Nurse Shortage Solutions Emerge

The ongoing nurse shortage in Indiana is being addressed through a strategic partnership between Jersey College and Lutheran Hospital, which originated in 2021. This collaboration emphasizes a Professional Nursing Program at the Fort Wayne campus, offering essential training to mitigate the looming crisis as …

Vinay Lochav | 30 July 2026

Inovio Pharmaceuticals (NASDAQ: INO) Reports $-0.28 EPS, Growth Signals Mixed Outlook

Inovio Pharmaceuticals (NASDAQ: INO) reported an earnings per share (EPS) of $-0.28 for the quarter ending March 31, significantly improving from the consensus expectation of $-0.35. This better-than-expected performance may provide a fleeting sense of optimism as investors navigate the company’s recent struggles and …

Vinay Lochav | 30 July 2026

LB Pharmaceuticals (NASDAQ: LBRX) Secures $150.0 million Private Placement to Fuel LB-102 Expansion

LB Pharmaceuticals disclosed a private placement that delivers $150.0 million in cash by issuing 3,577,560 common shares together with pre‑funded warrants that may be exercised to acquire up to 715,513 additional shares.

Vinay Lochav | 30 July 2026

ICON (NASDAQ: ICLR) Public Limited Company Shares Rise on Strong EPS of $2.50

ICON Public Limited Company (NASDAQ: ICLR) reported an earnings per share (EPS) of $2.50 for the quarter ending March 31, 2026, slightly above the anticipated $2.47. This performance highlights the company's resilience in a challenging market environment, especially as its net book-to-bill ratio has …

Vinay Lochav | 30 July 2026

Adaptive Biotechnologies Reports Q2 Loss Narrowing to $39.9M (NASDAQ: ADPT)

The company's revenue surged by 22% year-over-year to $71.6 million, outperforming expectations. This positive trend in earnings marks a notable moment for Adaptive, particularly as its minimal residual disease (MRD) segment became the cornerstone of revenue generation, contributing a substantial 92% of total sales. …

Vinay Lochav | 30 July 2026

Next FDA Decision on AVT16 BLA Looms After Alvotech (NYSE: OACB) Inspection

FDA Inspection Closed with Voluntary Action Indicated Finding

Vinay Lochav | 30 July 2026

Axogen (NASDAQ: AXGN) Increases Revenue Guidance to $279M Amid 23% Gain

Axogen, Inc. (NASDAQ: AXGN) raised its full-year revenue guidance to at least $279 million after reporting Q2 revenue of $69.7 million, reflecting a 23% year-on-year increase. This growth, coupled with an adjusted EPS of $0.12, positions Axogen favorably amid increasing demand for its nerve …

Vinay Lochav | 30 July 2026

Boston Scientific Reports Q2 2026 Earnings, EPS Hits $0.86 (NYSE: BSX)

Boston Scientific Corporation (NYSE: BSX) reported an impressive financial performance for the second quarter of 2026, achieving adjusted earnings per share (EPS) of $0.86, which exceeded the previously projected range of $0.82 to $0.84. This performance stands in contrast to a consensus estimate of …

Vinay Lochav | 30 July 2026

DataMeds AI Prepares for August 7 Distribution of Meme Coin

DataMeds AI, Inc. has made a significant adjustment in its schedule for distributing the Dream Bowl 2026 Meme Coin to shareholders, setting the new record date for August 7, 2026. This change means that holders will now receive 50 coins for every share of …

Vinay Lochav | 30 July 2026

Fortrea Holdings (NASDAQ: FTRE) Reports Q2 Income of $22.7M, Raises 2026 Guidance

Fortrea Holdings Inc. This outcome surpassed the consensus view held by market analysts.

Vinay Lochav | 30 July 2026
Support

Hi! How can we help you today?

Loading…